Ocimum Biosolutions Inc. Release: ASCENTA 4.0 Showcased at NASSCOM's Product Launchpad 2010

Published: Nov 16, 2010

Gaithersburg, Maryland, USA and Hyderabad, Andhra Pradesh, India, November 17, 2010: As a prelude to NASSCOM’s Product Conclave in Bangalore, 10 Companies were chosen to showcase new products at an exclusive interactive session with the media/blogger community. Of over 50 entries received, Ocimum Biosolutions’ new version of the ASCENTA® system was chosen in the top 10 to showcase its new features.

The ASCENTA® System has been providing a fast, easy, and affordable way to assess, prioritize, and qualify gene targets and potential biomarkers for over seven years. However, in a constant effort to provide better service, the interface is being upgraded from its current version 3.5 to 4.0 in December 2010. There is much to look forward for the research community in pharma, biotech and related academia from ASCENTA 4.0 as it comes fully loaded with more data and improved features that enhance user experience and yield better results.

About ASCENTA system: ASCENTA was conceived to simplify access and information retrieval from BioExpress, a comprehensive gene expression database. Ascenta is the reference software product that makes it possible for researchers to quickly identify and prioritize drug targets with respect to specific therapeutic and large-scale human biological considerations. In the past seven years Ascenta has been instrumental in the discovery and validation of several drug targets.

About Ocimum Biosolutions Ocimum Biosolutions is an leading integrated global genomics outsourcing partner with solutions spanning Bioresearch Design and Execution; Data Analytics and Insights; Laboratory, Sample & Data Management; and Integrated Solutions. Ocimum provides comprehensive genomic services and reference databases; data analysis; biorepository services such as sample accrual & collection, IRB approvals, CRO training, sample, clinical data capture and management; life science lab information management solutions; and also offers both research level and GLP-compliant services. Majority of the top 25 pharma & biotech companies and leading research institutes worldwide have chosen Ocimum as their preferred genomics outsourcing partner.

For more information, please visit www.ocimumbio.com.

Back to news